Acute intestinal pseudo-obstruction (Ogilvie's syndrome): A case report  by Nadukkandiyil, Navas et al.
lable at ScienceDirect
Journal of Clinical Gerontology & Geriatrics 5 (2014) 140e142Contents lists avaiJournal of Clinical Gerontology & Geriatrics
journal homepage: www.e- jcgg.comCase reportAcute intestinal pseudo-obstruction (Ogilvie’s syndrome): A case
report
Navas Nadukkandiyil, MD, Hanadi Khamis Alhamad, MD,
Luay Abdel Wahab, MBchB, MRCP, Essa Mubarak Al Sulaiti, MD,
Anoop Sankaranarayanan, MD, FRANZCP *
Department of Geriatric Medicine, Hamad Medical Corporation, Doha, Qatara r t i c l e i n f o
Article history:
Received 20 November 2013
Received in revised form
11 February 2014
Accepted 18 February 2014
Available online 13 April 2014
Keywords:
Acute geriatrics
Acute intestinal pseudo-obstruction
Elderly
Ogilvie’s syndrome* Corresponding author. Department of Geriatric
Hospital, Hamad Medical Corporation, PO Box 3050,
E-mail address: sanoop@hmc.org.qa (A. Sankarana
http://dx.doi.org/10.1016/j.jcgg.2014.02.003
2210-8335/Copyright  2014, Asia Paciﬁc League of Ca b s t r a c t
Acute colonic pseudo-obstruction, also known as Ogilvie’s syndrome, is an acute clinical condition with
clinical and radiological features of an acute large bowel obstruction in the absence of any mechanical
cause. Patients presenting with Ogilvie’s syndrome usually have underlying medical and surgical con-
ditions predisposing them to the syndrome. In this article, we describe an elderly patient who presented
with acute colonic pseudo-obstruction without any apparent cause.
Copyright  2014, Asia Paciﬁc League of Clinical Gerontology & Geriatrics. Published by Elsevier Taiwan
LLC. Open access under CC BY-NC-ND license.1. Introduction
Acute colonic pseudo-obstruction (ACPO) is also known as
Ogilvie’s syndrome after Sir Heneage Ogilvie who ﬁrst reported the
condition in 1948.1 It is characterized bymassive colonic distension
in the absence of mechanical obstruction (80e90%), abdominal
pain (80%), abdominal tenderness (62%), nausea and/or vomiting
(60%), obstipation (40%), and fever (37%).2 ACPO occurs most often
in hospitalized or institutionalized patients with serious underlying
medical and surgical conditions and is an important cause of
morbidity and mortality. The mortality rate is estimated at 40%
when ischemia or perforation occurs.2
A number of underlying causes have been described that pre-
dispose to ACPO.3,4 These include systemic illnesses such as post-
myocardial infarction or neurological illnesses such as Parkinson’s
disease, but are most likely to follow surgical interventions or
nonoperative trauma.
A number of medications have also been implicated including
antidepressants, antiparkinsonian medication, and opiates. Here
we describe a patient with ACPO without any apparent cause. TheMedicine, Hamad General
Doha, Qatar.
rayanan).
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2. Case report
Our patientwas a 74-year-old Iranianmalewho presented to the
acute geriatric departmentwith vomiting and abdominal distension
of 1 day’s duration. His vomitus was coffee ground in color, non-
bilious, and associated with watery diarrhea. The abdominal
distension was of sudden onset and was progressive in nature. He
also reported a low-grade fever (38C) for 1 day. The responsible
consultant undertook a comprehensive geriatric assessment on the
day of admission; the patient was an elderly male of stated agewho
was not bedridden, took oral feeds, and did not have an indwelling
catheter. His body mass index was 27.4 kg/m2. There was no evi-
dence of dry skin or pressure sores.
On systemic examination, he was clinically stable except for
mild tenderness in the right ileac fossa and increased bowel sounds
on auscultation. There was no other signiﬁcant past or medical
history that could have contributed to ACPO. He was only on los-
artan for his hypertension and did not receive any other medica-
tions; thus the possibility of drug-induced adynamic megacolon
was ruled out. There was no history to suggest trauma, infections,
or other potential cardiac or neurological causes for his abdominal
distension.ublished by Elsevier Taiwan LLC. Open access under CC BY-NC-ND license.
 
Fig. 2. Computed tomography of the abdomen conﬁrming dilated colon and absence
of any mechanical obstruction.
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gastroenterology consultation; however, there were no apparent
cause. Further, his investigations were noncontributory; three sets
of stool occult blood were negative, coagulation parameters were
normal, and there were no abnormalities of liver function tests.
In addition, ultrasound of the abdomen revealed no abnormal-
ities. Endoscopy could not be done in view of his acute condition.
All baseline investigations were within normal limits. X-ray of the
abdomen (erect) revealed marked dilatation (Fig. 1), especially of
the right colon. Contrast-enhanced computed tomography of the
abdomen revealed a dilated colon with colonic diameter exceeding
9 cm (Fig. 2). There was no evidence of any mechanical obstruction
noted. Barium enemawas deferred by the radiologist because of the
potential risk of colonic perforation due to massive dilatation.
We made a diagnosis of ACPO and decided to manage him
conservatively with a combination of bowel rest, nasogastric
tube decompression, and rectal tube placement. We also moni-
tored his abdominal girth routinely; the initial measurement was
140 cm. We monitored his electrolytes regularly and picked up
hypokalemia on the 3rd day; this was deemed secondary to
diarrhea and vomiting as his initial potassium (on admission)
was normal.
As the patient did not improve and showed signs of clinical
deterioration, we decided to stop conservative management on the
3rd day. At this point hewas treated with 2.5 mg neostigmine given
intravenously. He made good clinical improvement with a single
dose and his abdominal girth reduced to 86 cmwithin 24 hours. He
did not have any further recurrences. While colonoscopic decom-
pression would have been an alternative form of treatment,5 the
same was deferred on the gastroenterologist’s recommendation
considering the fact that the patient had a massive dilatation with
potential risk of colonic rupture during the procedure. Further ev-
idence suggests that colonoscopy is best reserved in patients for
whom conservative measures have failed or when neostigmine is
contraindicated.6
3. Discussion
Our patient presented with all the classical symptoms of ACPO:
abdominal distension, nausea, vomiting, fever, and abdominalFig. 1. X-ray of the abdomen showing dilated colon.tenderness. Interestingly, however, all investigations failed to
identify a cause for this manifestation.
Abnormalities of the autonomic nervous system, particularly
parasympathetic dysfunction have been used to explain the etiol-
ogy of ACPO. Although other factors have also been described, the
underlying pathophysiology is that of an early motor disturbance
followed by complete impairment of peristalsis with progressive
bowel dilatation.3 The condition has been described more often in
males, in the elderly, and following surgical interventions (partic-
ularly pelvic) and in the context of nonoperative trauma.2 Radio-
graphic studies are essential in differentiating Ogilvie’s syndrome
from other causes of large bowel distension.
Flat and upright radiography reveals a massively dilated colon
often limited to the cecum and right colon.7 The most feared
complication of Ogilvie’s syndrome is cecal perforation, which is
fortunately rare, occurring in only 1e3% of patients.8
Patients are usually given a trial of conservative management
provided cecal distension is< 12 cm and they are not exhibiting any
evidence of ischemic or perforated bowel. This involves bowel rest,
nasogastric tube decompression, and rectal tube placement and is
usually employed for 48e72 hours. In addition, patients should
undergo correction of electrolyte imbalances, discontinuation of
narcotics, and treatment of underlying infection.
Successful resolution is achieved in 83e96% of patients within
2e6 days of initiating therapy.9
Medical management is commenced when the patient dem-
onstrates clinical deterioration or increasing cecal distension
beyond 12 cm. This is usually directed at counteracting the sym-
patheticeparasympathetic imbalance associated with Ogilvie’s.
The best evidence for medical treatment is available for neostig-
mine.3 Neostigmine is a reversible acetyl cholinesterase inhibitor
that indirectly stimulates the muscarinic receptors and enhances
colonic motor activity.4 Neostigmine may be repeated for patients
with an incomplete response, patients without a response, or those
with a recurrence. If the second dose of neostigmine fails to resolve
the cecal dilatation, the patient should proceed to more aggressive
measures of decompression. As far as we are aware, there are no
contraindications for the use of neostigmine among patients of
Iranian descent; in fact a recent study by Aghadavoudi et al,10
sought to study the effectiveness of neostigmine in Iran in other
settings with good outcome.
N. Nadukkandiyil et al. / Journal of Clinical Gerontology & Geriatrics 5 (2014) 140e142142In conclusion, Ogilvie’s syndrome is still a rare disorder; we are
aware of only two other reports from this region.11,12 Although the
illness typically occurs in the context of some other primary
problem, it can also occur without any apparent predisposing cause
as in the case of our patient; apart from the fact that he was elderly
our patient did not have any other apparent predisposing condi-
tions. Timely recognition is of utmost importance in the assessment
and management of patients with ACPO and to avoid and reduce
morbidity and mortality.
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